Monthly information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2022
Monthly information regarding the total number of voting rights and total number of shares of…
Monthly information regarding the total number of voting rights and total number of shares of…
DURHAM, N.C., May 17, 2022 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it…
SOUTH SAN FRANCISCO and SAN DIEGO, Calif., May 17, 2022 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
ERYTECH to Present at the H.C. Wainwright Global Investment Conference Cambridge, MA (U.S.) and Lyon…
REDWOOD CITY, Calif., May 17, 2022 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading…
EMERYVILLE, Calif., May 17, 2022 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty…
SAN DIEGO, May 17, 2022 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics…
AUSTIN, Texas, May 17, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,”…
WALTHAM, Mass., May 17, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (NASDAQ: CINC) today announced…
SAN DIEGO, CA and TAICANG, China, May 17, 2022 (GLOBE NEWSWIRE) — Connect Biopharma Holdings…
MONT-SAINT-GUIBERT, Belgium, May 17, 2022 (GLOBE NEWSWIRE) — Celyad Oncology SA (Euronext & Nasdaq: CYAD)…
Methemoglobin (MetHb) and Nitrogen Dioxide (NO2) Levels (<10% and <5 ppm, respectively are safe)* *Graphs…
– Human equivalent ADVM-022 dose of 6E10 vg/eye provided therapeutic levels of aflibercept in NHPs…
Daniel Barber, current Chief Operating Officer of Aquestive, appointed as President and Chief Executive Officer…
CAMBRIDGE, Mass., May 17, 2022 (GLOBE NEWSWIRE) — Casma Therapeutics, Inc., a biotechnology company engaging…
LEXINGTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”)…
BOSTON and LOUISVILLE, Ky., May 17, 2022 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc. (Nasdaq: TALS),…
ROCKVILLE, MD, May 17, 2022 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company…
PERHAM, Minn., May 17, 2022 (GLOBE NEWSWIRE) — Arvig is now offering a new series…
The STRIDE program launches in the Fall of 2022 and a female entrepreneur’s STRIDE program…